Table 1. SNP markers and association in follow-up study.
(A) Dutch (446 cases, 641 controls) | (B) Finnish (623 cases, 359 healthy) | (C) Hungarian (592 cases, 471 healthy) | (D) Finnish, Hungarian, Dutch (1661 cases, 1471 controls) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Markers | Position (bp) | Alleles | Case, contr freq | P value | emp P-value | OR (95% CI) | Case, contr freq | P value | OR (95% CI) | Case, contr freq | P value | OR (95% CI) | Case, contr freq | P value | OR (95% CI) |
rs1648957 | 104613397 | CT | 0.498, 0.433 | 0.003 | 0.005 | 1.30 (1.09–1.55) | 0.449, 0.481 | 0.351 | 0.545, 0.519 | 0.440 | 0.498, 0.460 | 0.085 | |||
rs9391227 | 105265327 | AT | 0.497, 0.559 | 0.005 | 0.003 | 0.78 (0.66–0.93) | 0.541, 0.651 | 0.003* | 0.66 (0.49–0.88) | 0.495, 0.555 | 0.054 | 0.507, 0.577 | 3.07 × 10−5* | 0.76 (0.66–0.86) | |
rs2895615 | 106292441 | CG | 0.690, 0.642 | 0.020 | 0.018 | 1.25 (1.03–1.50) | 0.668, 0.641 | 0.398 | 0.679, 0.678 | 0.871 | 0.683, 0.649 | 0.061 | |||
rs2216084 | 107660005 | CT | 0.646, 0.688 | 0.045 | 0.058 | 0.83 (0.69–0.99) | 0.809, 0.757 | 0.048 | 1.41 (0.99–1.99) | 0.706, 0.676 | 0.603 | 0.700, 0.699 | 0.836 | ||
rs1146229 | 109205720 | CT | 0.085, 0.052 | 0.002 | 0.003 | 1.72 (1.22–2.43) | 0.111, 0.118 | 0.673 | 0.070, 0.095 | 0.082 | 0.087, 0.075 | 0.259 | |||
rs9487060 | 109741149 | CG | 0.079, 0.048 | 0.003 | 0.002 | 1.73 (1.21–2.47) | 0.067, 0.072 | 0.724 | 0.060, 0.062 | 0.763 | 0.072, 0.054 | 0.032 | 1.36 (1.03–1.79) | ||
rs2503770 | 110373108 | AT | 0.233, 0.274 | 0.031 | 0.028 | 0.80 (0.66–0.98) | 0.324, 0.313 | 0.884 | 0.237, 0.217 | 0.376 | 0.255, 0.269 | 0.536 | |||
rs571060 | 112403213 | CT | 0.970, 0.987 | 0.007 | 0.010 | 0.44 (0.24–0.81) | 0.992, 0.993 | 1.000 | 0.982, 0.978 | 0.841 | 0.978, 0.986 | 0.085 | |||
rs2282854 | 112638353 | CT | 0.933, 0.962 | 0.003 | 0.003 | 0.55 (0.37–0.82) | 0.968, 0.965 | 0.796 | 0.948, 0.938 | 0.452 | 0.946, 0.958 | 0.170 | |||
rs4946111 | 116091112 | GT | 0.445, 0.502 | 0.011 | 0.008 | 0.80 (0.67–0.95) | 0.385, 0.482 | 0.007 | 0.66 (0.49–0.90) | 0.434, 0.390 | 0.280 | 0.429, 0.474 | 0.020 | 0.86 (0.76–0.98) | |
rs1998166 | 117020110 | CT | 0.921, 0.877 | 0.001 | 0.003 | 1.62 (1.20–2.19) | 0.940, 0.917 | 0.105 | 0.956, 0.928 | 0.087 | 0.934, 0.896 | 2.17 × 10−4* | 1.56 (1.22–1.98) | ||
rs4946578 | 121936760 | AG | 0.584, 0.534 | 0.023 | 0.023 | 1.23 (1.03–1.46) | 0.732, 0.695 | 0.323 | 0.564, 0.536 | 0.421 | 0.606, 0.558 | 0.002 | 1.25 (1.09–1.44) |
Abbreviations: contr, control; freq, frequency.
SNP markers in the study and their association to celiac disease in Dutch cases and controls (A) as well as Finnish (B) and Hungarian (C) families, and a meta-analysis of all three populations (D). Case frequencies, in the family materials, refer to the allele frequencies of the affected offspring (‘cases') and the control frequencies refer to both unaffected offspring (‘healthy') and the untransmitted alleles in parents. P-values lower than 0.01 are considered significant (marked in bold) and odds ratios (OR) and 95% confidence intervals for significant markers are given.
Emp permutation P-values are based on 10 000 permutations.